;PMID: 9794700
;source_file_629.mrg
;Release 0.9 of PennBioIE
;Funded by NSF ITR EIA-0205448

;0)section:[e:0..40] = [t:0..40]
;1)sentence:[e:46..99] = [t:46..99]
;2)section:[e:103..180] = [t:103..180]
;3)section:[e:184..300] = [t:184..300]
;4)sentence:[e:304..533] = [t:304..533]
;5)sentence:[e:534..730] = [t:534..730]
;6)sentence:[e:731..861] = [t:731..861]
;7)sentence:[e:862..994] = [t:862..994]
;8)sentence:[e:995..1096] = [t:995..1096]
;9)sentence:[e:1097..1275] = [t:1097..1275]
;10)sentence:[e:1276..1580] = [t:1276..1580]
;11)sentence:[e:1581..1671] = [t:1581..1671]
;12)sentence:[e:1672..1825] = [t:1672..1825]
;13)sentence:[e:1826..1891] = [t:1826..1891]
;14)section:[e:1895..1939] = [t:1895..1939]

;section 0 Span:0..40
;J Lab Clin Med. 1998 Oct;132(4):294-302.
(SEC
  (FRAG (NNP:[0..1] J) (NNP:[2..5] Lab) (NNP:[6..10] Clin) (NNP:[11..14] Med)
        (.:[14..15] .) (CD:[16..20] 1998) (JJ:[21..27] Oct;13) (CD:[27..28] 2)
        (NN:[28..29] -LRB-) (NN:[29..30] 4) (NN:[30..31] -RRB-) (,:[31..32] :)
        (CD:[32..34] 29) (CD:[34..39] 4-302) (.:[39..40] .)))

;sentence 1 Span:46..99
;Metabolism of ethanol by rat pancreatic acinar cells.
;[60..67]:substance:"ethanol"
(SENT
  (NP-HLN
    (NP (NN:[46..56] Metabolism))
    (PP (IN:[57..59] of)
      (NP (NN:[60..67] ethanol)))
    (PP (IN:[68..70] by)
      (NP (NN:[71..74] rat) (JJ:[75..85] pancreatic) (JJ:[86..92] acinar)
          (NNS:[93..98] cells)))
    (.:[98..99] .)))

;section 2 Span:103..180
;Haber PS, Apte MV, Applegate TL, Norton ID, Korsten MA, Pirola RC, Wilson
;JS.
(SEC
  (FRAG (IN:[103..108] Haber) (NNP:[109..111] PS) (,:[111..112] ,)
        (NNP:[113..117] Apte) (NNP:[118..120] MV) (,:[120..121] ,)
        (NNP:[122..131] Applegate) (NNP:[132..134] TL) (,:[134..135] ,)
        (NNP:[136..142] Norton) (NNP:[143..145] ID) (,:[145..146] ,)
        (NNP:[147..154] Korsten) (NNP:[155..157] MA) (,:[157..158] ,)
        (NNP:[159..165] Pirola) (NNP:[166..168] RC) (,:[168..169] ,)
        (NNP:[170..176] Wilson) (NNP:[177..180] JS.)))

;section 3 Span:184..300
;Department of Gastroenterology, Prince of Wales Hospital, and the University
;of  New South Wales, Sydney, Australia.
(SEC
  (FRAG (NNP:[184..194] Department) (IN:[195..197] of)
        (NNP:[198..214] Gastroenterology) (,:[214..215] ,)
        (NNP:[216..222] Prince) (IN:[223..225] of) (NNP:[226..231] Wales)
        (NNP:[232..240] Hospital) (,:[240..241] ,) (VBZ:[242..245] and)
        (DT:[246..249] the) (NNP:[250..260] University) (IN:[261..263] of)
        (NNP:[265..268] New) (NNP:[269..274] South) (NNP:[275..280] Wales)
        (,:[280..281] ,) (NNP:[282..288] Sydney) (,:[288..289] ,)
        (NNP:[290..299] Australia) (.:[299..300] .)))

;sentence 4 Span:304..533
;It has been postulated that ethanol-induced pancreatic injury may be mediated
;by  the oxidation of ethanol within the pancreas with secondary toxic
;metabolic  changes, but there is little evidence of pancreatic ethanol
;oxidation.
;[332..339]:substance:"ethanol"
;[403..410]:substance:"ethanol"
;[515..522]:substance:"ethanol"
(SENT
  (S
    (NP-SBJ-2
      (NP (PRP:[304..306] It))
      (SBAR-1 (-NONE-:[306..306] *EXP*)))
    (VP (VBZ:[307..310] has)
      (VP (VBN:[311..315] been)
        (VP (VBN:[316..326] postulated)
          (NP-2 (-NONE-:[326..326] *))
          (SBAR-1 (IN:[327..331] that)
            (S
              (S
                (NP-SBJ-3
                  (NML (NN:[332..339] ethanol) (HYPH:[339..340] -)
                       (VBN:[340..347] induced))
                  (JJ:[348..358] pancreatic) (NN:[359..365] injury))
                (VP (MD:[366..369] may)
                  (VP (VB:[370..372] be)
                    (VP (VBN:[373..381] mediated)
                      (NP-3 (-NONE-:[381..381] *))
                      (PP (IN:[382..384] by)
                        (NP-LGS
                          (NP (DT:[386..389] the) (NN:[390..399] oxidation))
                          (PP (IN:[400..402] of)
                            (NP
                              (NP (NN:[403..410] ethanol))
                              (PP-LOC (IN:[411..417] within)
                                (NP (DT:[418..421] the) (NN:[422..430] pancreas)))))))
                      (PP (IN:[431..435] with)
                        (NP (JJ:[436..445] secondary) (JJ:[446..451] toxic)
                            (JJ:[452..461] metabolic) (NNS:[463..470] changes)))))))
              (,:[470..471] ,) (CC:[472..475] but)
              (S
                (NP-SBJ (EX:[476..481] there))
                (VP (VBZ:[482..484] is)
                  (NP-PRD
                    (NP (JJ:[485..491] little) (NN:[492..500] evidence))
                    (PP (IN:[501..503] of)
                      (NP (JJ:[504..514] pancreatic) (NN:[515..522] ethanol)
                          (NN:[523..532] oxidation)))))))))))
    (.:[532..533] .)))

;sentence 5 Span:534..730
;The aims  of this study were to determine whether pancreatic acinar cells
;metabolize  significant amounts of ethanol and, if so, to compare their rate
;of ethanol  oxidation to that of hepatocytes.
;[643..650]:substance:"ethanol"
;[688..695]:substance:"ethanol"
(SENT
  (S
    (NP-SBJ
      (NP (DT:[534..537] The) (NNS:[538..542] aims))
      (PP (IN:[544..546] of)
        (NP (DT:[547..551] this) (NN:[552..557] study))))
    (VP (VBD:[558..562] were)
      (S-PRP-PRD
        (S
          (NP-SBJ (-NONE-:[562..562] *))
          (VP (TO:[563..565] to)
            (VP (VB:[566..575] determine)
              (SBAR (IN:[576..583] whether)
                (S
                  (NP-SBJ (JJ:[584..594] pancreatic) (JJ:[595..601] acinar)
                          (NNS:[602..607] cells))
                  (VP (VBP:[608..618] metabolize)
                    (NP
                      (NP (JJ:[620..631] significant) (NNS:[632..639] amounts))
                      (PP (IN:[640..642] of)
                        (NP (NN:[643..650] ethanol))))))))))
        (CC:[651..654] and) (,:[654..655] ,)
        (S
          (SBAR-ADV (IN:[656..658] if)
            (FRAG
              (ADVP (RB:[659..661] so))))
          (,:[661..662] ,)
          (NP-SBJ (-NONE-:[662..662] *))
          (VP (TO:[663..665] to)
            (VP (VB:[666..673] compare)
              (NP
                (NP (DT:[674..679] their) (NN:[680..684] rate))
                (PP (IN:[685..687] of)
                  (NP (NN:[688..695] ethanol) (NN:[697..706] oxidation))))
              (PP-CLR (TO:[707..709] to)
                (NP
                  (NP (DT:[710..714] that))
                  (PP (IN:[715..717] of)
                    (NP (NNS:[718..729] hepatocytes))))))))))
    (.:[729..730] .)))

;sentence 6 Span:731..861
;Cultured rat pancreatic acinar cells and  hepatocytes were incubated with 5
;to 50 mmol/L carbon 14-labeled ethanol (25  dpm/nmol).
;[805..812]:quantitative-value:"5 to 50"
;[813..819]:quantitative-units:"mmol/L"
;[820..829]:substance:"carbon 14"
;[838..845]:substance:"ethanol"
;[847..849]:quantitative-value:"25"
;[851..859]:quantitative-units:"dpm/nmol"
(SENT
  (S
    (NP-SBJ-1
      (NP
        (NML-2 (JJ:[731..739] Cultured) (NN:[740..743] rat)
               (JJ:[744..754] pancreatic) (JJ:[755..761] acinar))
        (NNS:[762..767] cells))
      (CC:[768..771] and)
      (NP
        (NML-2 (-NONE-:[771..771] *P*))
        (NNS:[773..784] hepatocytes)))
    (VP (VBD:[785..789] were)
      (VP (VBN:[790..799] incubated)
        (NP-1 (-NONE-:[799..799] *))
        (PP (IN:[800..804] with)
          (NP
            (NML
              (NML
                (QP (CD:[805..806] 5) (TO:[807..809] to) (CD:[810..812] 50))
                (NN:[813..817] mmol))
              (PP (SYM:[817..818] /)
                (NP (NN:[818..819] L))))
            (ADJP
              (NML (NN:[820..826] carbon) (CD:[827..829] 14))
              (HYPH:[829..830] -) (VBN:[830..837] labeled))
            (NN:[838..845] ethanol)
            (PRN (-LRB-:[846..847] -LRB-)
              (NP
                (NP (CD:[847..849] 25) (NN:[851..854] dpm))
                (PP (SYM:[854..855] /)
                  (NP (NN:[855..859] nmol))))
              (-RRB-:[859..860] -RRB-))))))
    (.:[860..861] .)))

;sentence 7 Span:862..994
;Ethanol oxidation was calculated from the production of 14C-labeled  acetate
;that was isolated by Dowex ion-exchange chromatography.
;[862..869]:substance:"Ethanol"
;[918..921]:substance:"14C"
;[931..938]:substance:"acetate"
(SENT
  (S
    (NP-SBJ-2 (NN:[862..869] Ethanol) (NN:[870..879] oxidation))
    (VP (VBD:[880..883] was)
      (VP (VBN:[884..894] calculated)
        (NP-2 (-NONE-:[894..894] *))
        (PP (IN:[895..899] from)
          (NP
            (NP (DT:[900..903] the) (NN:[904..914] production))
            (PP (IN:[915..917] of)
              (NP
                (NP
                  (ADJP (NN:[918..921] 14C) (HYPH:[921..922] -)
                        (VBN:[922..929] labeled))
                  (NN:[931..938] acetate))
                (SBAR
                  (WHNP-1 (WDT:[939..943] that))
                  (S
                    (NP-SBJ-1 (-NONE-:[943..943] *T*))
                    (VP (VBD:[944..947] was)
                      (VP (VBN:[948..956] isolated)
                        (NP-1 (-NONE-:[956..956] *))
                        (PP-MNR (IN:[957..959] by)
                          (NP (NNP:[960..965] Dowex)
                            (NML (NN:[966..969] ion) (HYPH:[969..970] -)
                                 (NN:[970..978] exchange))
                            (NN:[979..993] chromatography)))))))))))))
    (.:[993..994] .)))

;sentence 8 Span:995..1096
;Ethanol  oxidation by pancreatic acinar cells was demonstrable at all ethanol
; concentrations tested.
;[995..1002]:substance:"Ethanol"
;[1065..1072]:substance:"ethanol"
(SENT
  (S
    (NP-SBJ
      (NP (NN:[995..1002] Ethanol) (NN:[1004..1013] oxidation))
      (PP (IN:[1014..1016] by)
        (NP (JJ:[1017..1027] pancreatic) (JJ:[1028..1034] acinar)
            (NNS:[1035..1040] cells))))
    (VP (VBD:[1041..1044] was)
      (ADJP-PRD (JJ:[1045..1057] demonstrable))
      (PP-LOC (IN:[1058..1060] at)
        (NP
          (NP (DT:[1061..1064] all) (NN:[1065..1072] ethanol)
              (NNS:[1074..1088] concentrations))
          (VP (VBN:[1089..1095] tested)
            (NP (-NONE-:[1095..1095] *))))))
    (.:[1095..1096] .)))

;sentence 9 Span:1097..1275
;At an intoxicating ethanol concentration (50 mmol/L),  14C-labeled acetate
;production (227+/-20 nmol/10(6) cells/h) approached that of  hepatocytes
;(337+/-61 nmol/10(6) cells/h).
;[1116..1123]:substance:"ethanol"
;[1139..1141]:quantitative-value:"50"
;[1142..1148]:quantitative-units:"mmol/L"
;[1152..1155]:substance:"14C"
;[1164..1171]:substance:"acetate"
;[1184..1192]:quantitative-value:"227+/-20"
;[1193..1211]:quantitative-units:"nmol/10(6) cells/h"
;[1246..1254]:quantitative-value:"337+/-61"
;[1255..1273]:quantitative-units:"nmol/10(6) cells/h"
(SENT
  (S
    (PP (IN:[1097..1099] At)
      (NP (DT:[1100..1102] an) (VBG:[1103..1115] intoxicating)
          (NN:[1116..1123] ethanol) (NN:[1124..1137] concentration)
        (PRN (-LRB-:[1138..1139] -LRB-)
          (NP
            (NP (CD:[1139..1141] 50) (NN:[1142..1146] mmol))
            (PP (SYM:[1146..1147] /)
              (NP (NN:[1147..1148] L))))
          (-RRB-:[1148..1149] -RRB-))))
    (,:[1149..1150] ,)
    (NP-SBJ
      (NP
        (NML
          (ADJP (NN:[1152..1155] 14C) (HYPH:[1155..1156] -)
                (VBN:[1156..1163] labeled))
          (NN:[1164..1171] acetate))
        (NN:[1172..1182] production))
      (PRN (-LRB-:[1183..1184] -LRB-)
        (NP
          (NP
            (QP (CD:[1184..1187] 227) (SYM:[1187..1190] +/-)
                (CD:[1190..1192] 20))
            (NN:[1193..1197] nmol))
          (PP (SYM:[1197..1198] /)
            (NP (CD:[1198..1203] 10-LRB-6-RRB-) (NNS:[1204..1209] cells)))
          (PP (SYM:[1209..1210] /)
            (NP (NN:[1210..1211] h))))
        (-RRB-:[1211..1212] -RRB-)))
    (VP (VBD:[1213..1223] approached)
      (NP
        (NP (DT:[1224..1228] that))
        (PP (IN:[1229..1231] of)
          (NP (NNS:[1233..1244] hepatocytes)))
        (PRN (-LRB-:[1245..1246] -LRB-)
          (NP
            (NP
              (QP (CD:[1246..1249] 337) (SYM:[1249..1252] +/-)
                  (CD:[1252..1254] 61))
              (NN:[1255..1259] nmol))
            (PP (SYM:[1259..1260] /)
              (NP (CD:[1260..1265] 10-LRB-6-RRB-) (NNS:[1266..1271] cells)))
            (PP (SYM:[1271..1272] /)
              (NP (NN:[1272..1273] h))))
          (-RRB-:[1273..1274] -RRB-))))
    (.:[1274..1275] .)))

;sentence 10 Span:1276..1580
;Phenanthroline (an inhibitor of  classes I through III isoenzymes of alcohol
;dehydrogenase (ADH)) inhibited  pancreatic ethanol oxidation by 90%, but
;4-methylpyrazole (a class I and II ADH  inhibitor), carbon monoxide (a
;cytochrome P450 inhibitor), and sodium azide (a  catalase inhibitor) had no
;effect.
;[1276..1290]:substance:"Phenanthroline"
;[1295..1304]:substance:"inhibitor"
;[1309..1341]:substance:"classes I through III isoenzymes"
;[1345..1366]:substance:"alcohol dehydrogenase"
;[1368..1371]:substance:"ADH"
;[1396..1403]:substance:"ethanol"
;[1417..1420]:quantitative-value:"90%"
;[1426..1442]:substance:"4-methylpyrazole"
;[1446..1453]...[1461..1464]:substance:"class I"..."ADH"
;[1446..1451]...[1458..1464]:substance:"class"..."II ADH"
;[1466..1475]:substance:"inhibitor"
;[1478..1493]:substance:"carbon monoxide"
;[1497..1512]:cyp450:"cytochrome P450"
;[1513..1522]:substance:"inhibitor"
;[1529..1541]:substance:"sodium azide"
;[1546..1554]:substance:"catalase"
;[1555..1564]:substance:"inhibitor"
(SENT
  (S
    (S
      (NP-SBJ (NN:[1276..1290] Phenanthroline)
        (PRN (-LRB-:[1291..1292] -LRB-)
          (NP
            (NP (DT:[1292..1294] an) (NN:[1295..1304] inhibitor))
            (PP (IN:[1305..1307] of)
              (NP
                (NP
                  (NML
                    (NML-1 (NNS:[1309..1316] classes))
                    (CD:[1317..1318] I)
                    (PP (IN:[1319..1326] through)
                      (NP
                        (NML-1 (-NONE-:[1326..1326] *P*))
                        (CD:[1327..1330] III))))
                  (NNS:[1331..1341] isoenzymes))
                (PP (IN:[1342..1344] of)
                  (NP
                    (NP (NN:[1345..1352] alcohol)
                        (NN:[1353..1366] dehydrogenase))
                    (NP (-LRB-:[1367..1368] -LRB-) (NN:[1368..1371] ADH)
                        (-RRB-:[1371..1372] -RRB-)))))))
          (-RRB-:[1372..1373] -RRB-)))
      (VP (VBD:[1374..1383] inhibited)
        (NP (JJ:[1385..1395] pancreatic) (NN:[1396..1403] ethanol)
            (NN:[1404..1413] oxidation))
        (PP-EXT (IN:[1414..1416] by)
          (NP (CD:[1417..1419] 90) (NN:[1419..1420] %)))))
    (,:[1420..1421] ,) (CC:[1422..1425] but)
    (S
      (NP-SBJ
        (NP (NN:[1426..1442] 4-methylpyrazole)
          (PRN (-LRB-:[1443..1444] -LRB-)
            (NP (DT:[1444..1445] a)
              (NML
                (NML
                  (NML
                    (NML-2 (NN:[1446..1451] class))
                    (CD:[1452..1453] I))
                  (NML-3 (-NONE-:[1453..1453] *P*)))
                (CC:[1454..1457] and)
                (NML
                  (NML
                    (NML-2 (-NONE-:[1457..1457] *P*))
                    (CD:[1458..1460] II))
                  (NML-3 (NN:[1461..1464] ADH) (NN:[1466..1475] inhibitor)))))
            (-RRB-:[1475..1476] -RRB-)))
        (,:[1476..1477] ,)
        (NP
           (NN:[1478..1484] carbon) (NN:[1485..1493] monoxide)
          (PRN (-LRB-:[1494..1495] -LRB-)
            (NP (DT:[1495..1496] a)
              (NML (NN:[1497..1507] cytochrome) (NN:[1508..1512] P450))
              (NN:[1513..1522] inhibitor))
            (-RRB-:[1522..1523] -RRB-)))
        (,:[1523..1524] ,) (CC:[1525..1528] and)
        (NP
           (NN:[1529..1535] sodium) (NN:[1536..1541] azide)
          (PRN (-LRB-:[1542..1543] -LRB-)
            (NP (DT:[1543..1544] a) (NN:[1546..1554] catalase)
                (NN:[1555..1564] inhibitor))
            (-RRB-:[1564..1565] -RRB-))))
      (VP (VBD:[1566..1569] had)
        (NP (DT:[1570..1572] no) (NN:[1573..1579] effect))))
    (.:[1579..1580] .)))

;sentence 11 Span:1581..1671
;This study has shown that pancreatic acinar  cells oxidize significant
;amounts of ethanol.
;[1663..1670]:substance:"ethanol"
(SENT
  (S
    (NP-SBJ (DT:[1581..1585] This) (NN:[1586..1591] study))
    (VP (VBZ:[1592..1595] has)
      (VP (VBN:[1596..1601] shown)
        (SBAR (IN:[1602..1606] that)
          (S
            (NP-SBJ (JJ:[1607..1617] pancreatic) (JJ:[1618..1624] acinar)
                    (NNS:[1626..1631] cells))
            (VP (VBP:[1632..1639] oxidize)
              (NP
                (NP (JJ:[1640..1651] significant) (NNS:[1652..1659] amounts))
                (PP (IN:[1660..1662] of)
                  (NP (NN:[1663..1670] ethanol)))))))))
    (.:[1670..1671] .)))

;sentence 12 Span:1672..1825
;At intoxicating concentrations of  ethanol, pancreatic acinar cell ethanol
;oxidation may have the potential to  contribute to pancreatic cellular
;injury.
;[1707..1714]:substance:"ethanol"
;[1739..1746]:substance:"ethanol"
(SENT
  (S
    (PP (IN:[1672..1674] At)
      (NP
        (NP (VBG:[1675..1687] intoxicating) (NNS:[1688..1702] concentrations))
        (PP (IN:[1703..1705] of)
          (NP (NN:[1707..1714] ethanol)))))
    (,:[1714..1715] ,)
    (NP-SBJ
      (NML (JJ:[1716..1726] pancreatic) (JJ:[1727..1733] acinar)
           (NN:[1734..1738] cell))
      (NN:[1739..1746] ethanol) (NN:[1747..1756] oxidation))
    (VP (MD:[1757..1760] may)
      (VP (VB:[1761..1765] have)
        (NP (DT:[1766..1769] the) (NN:[1770..1779] potential)
          (S
            (NP-SBJ (-NONE-:[1779..1779] *))
            (VP (TO:[1780..1782] to)
              (VP (VB:[1784..1794] contribute)
                (PP-CLR (TO:[1795..1797] to)
                  (NP (JJ:[1798..1808] pancreatic) (JJ:[1809..1817] cellular)
                      (NN:[1818..1824] injury)))))))))
    (.:[1824..1825] .)))

;sentence 13 Span:1826..1891
;The mechanism appears to involve the  class III isoenzyme of ADH.
;[1864..1883]:substance:"class III isoenzyme"
;[1887..1890]:substance:"ADH"
(SENT
  (S
    (NP-SBJ (DT:[1826..1829] The) (NN:[1830..1839] mechanism))
    (VP (VBZ:[1840..1847] appears)
      (S
        (NP-SBJ (-NONE-:[1847..1847] *))
        (VP (TO:[1848..1850] to)
          (VP (VB:[1851..1858] involve)
            (NP
              (NP (DT:[1859..1862] the)
                
                (NML (NN:[1864..1869] class) (CD:[1870..1873] III))
                (NN:[1874..1883] isoenzyme))
              (PP (IN:[1884..1886] of)
                (NP (NN:[1887..1890] ADH))))))))
    (.:[1890..1891] .)))

;section 14 Span:1895..1939
;PMID: 9794700 [PubMed - indexed for MEDLINE]
(SEC
  (FRAG (NNP:[1895..1899] PMID) (::[1899..1900] :) (CD:[1901..1908] 9794700)
        (NN:[1909..1910] -LSB-) (NNP:[1910..1916] PubMed) (::[1917..1918] -)
        (NN:[1919..1926] indexed) (IN:[1927..1930] for)
        (NNP:[1931..1939] MEDLINE-RSB-)))
